JBMRThe American Society for Bone and Mineral Research

 Perspective
Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches
Joy Y Wu 1, David T Scadden 2 3, Henry M Kronenberg 1 *
1Endocrine Unit, Boston, Massachusetts, USA
2Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
3Harvard Stem Cell Institute, Cambridge, Massachusetts, USA
email: Henry M Kronenberg (hkronenberg@partners.org)

*Correspondence to Henry M Kronenberg, Address correspondence to: Henry M. Kronenberg, MD, Endocrine Unit, Massachusetts General Hospital, 50 Blossom Street, Thier 1101, Boston, MA 02114, USA

Dr. Scadden is a consultant and shareholder in Fate Therapeutics, a consultant for Genzyme and a Scientific Advisory Board Member for Hospira. All other authors state that they have no conflicts of interest.

First page of article
No Abstract

Received: 15 December 2008; Revised: 12 January 2009; Accepted: 12 February 2009

Digital Object Identifier (DOI)

10.1359/jbmr.090225  About DOI

Search the Site

Search

Site Adverts

Login on ASBMR Site

ASBMR Annual Meeting 2010